23 news items
Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy
MRK
9 May 24
a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities
Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
MRK
9 May 24
of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
MRK
8 May 24
, sustainable and healthy future for all people and communities. For more information, visit
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
MRK
1 May 24
to enable a safe, sustainable and healthy future for all people and communities. For more information, visit
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
MRK
29 Apr 24
a safe, sustainable and healthy future for all people and communities. For more information, visit
osnfu9p93he hem5eqheqt1wwx507g1zmjesjve2d
MRK
25 Apr 24
a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people
z3ypac1zqd37yxu1a8fhpbqu2xo
ABBV
ATNM
AZN
22 Apr 24
of sustained outperformance, especially if interest rates trend downwards coupled with continuous innovation and active M
3xe6qgxqmvttux5j1 17
MRK
19 Apr 24
and operate responsibly every day to enable a safe, sustainable, and healthy future for all people and communities. For more information about our
bdwtngbfldf0 n7vwcl81ogielmd6wco9bbnfyh2gp6jlgs2x
MRK
MRNA
9 Apr 24
, and 8 (36.4%) stable disease at data cutoff.
Sustained de novo T cell induction to targeted neoantigens was seen in 5/5 available patient
6xo94anicd1f8gz9fsu8qanmci8jblq92pwj8pq625fpp3dxsf32lr19al
MRK
4 Apr 24
global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more
gkhgxmxfq6d0ary9
MRK
28 Mar 24
, sustainable and healthy future for all people and communities. For more information, visit
byh5pq7z33zgycy2pl8cq9mib496z 4xqzcu8mzgzc7u136y9es
MRK
26 Mar 24
in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy
vunp7pvuy7g4i4jr24g85z4u3i14d qxhycrl912errg
MRK
15 Mar 24
efficiency, productivity, and profitability, while prioritizing animal welfare, biosecurity and sustainability
cc1hh9w1722 syxwn
MRK
15 Mar 24
workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information
de8l7vo7ejgax
MRK
13 Mar 24
, sustainable and healthy future for all people and communities. For more information, visit
ewjefdkxq8phqj601sw5u
HARP
MRK
11 Mar 24
and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all
obmr1gjzbdpodx5w6zj0
GILD
MRK
6 Mar 24
day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit
uc8f93h80w2ptv2q6fi04 sn5vh8hnwmhk65d
MRK
5 Mar 24
. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people
pmvewywgeplsw8xtzekpv4bnlc7v nmln2oywx16ydont10
MRK
4 Mar 24
a safe, sustainable and healthy future for all people and communities. For more information, visit
wjqttdczfyhgr98zto62fou3iujq2a6m0guvz2662gd27tjsv0hh0ja
AAPL
AMGN
GS
1 Mar 24
the company's decelerating revenue growth is only a pause on its path to "a sustained highly profitable growth trajectory." Analyst Kash Rangan said